2016
DOI: 10.1016/j.immuni.2016.09.013
|View full text |Cite
|
Sign up to set email alerts
|

Deficient Activity of the Nuclease MRE11A Induces T Cell Aging and Promotes Arthritogenic Effector Functions in Patients with Rheumatoid Arthritis

Abstract: Immune aging manifests with a combination of failing adaptive immunity and insufficiently restrained inflammation. In patients with rheumatoid arthritis (RA), T cell aging occurs prematurely, but the mechanisms involved and their contribution to tissue-destructive inflammation remain unclear. We found that RA CD4+ T cells showed signs of aging during their primary immune responses and differentiated into tissue-invasive, pro-inflammatory effector cells. RA T cells had low expression of the double-strand-break … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
92
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 95 publications
(93 citation statements)
references
References 57 publications
(64 reference statements)
1
92
0
Order By: Relevance
“…MRE11 inhibition in healthy T cells induced the aging phenotype, whereas MRE11 overexpression in rheumatoid arthritis T cells reverses it. The observation that the premature T cell aging is linked to MRE11 and telomere deprotection suggests MRE11 as a therapeutic target for immune aging and suppressing dysregulated inflammation (189). We expect that further knowledge of MRN biochemical mechanisms will be key to an improved understanding and intervention in multiple diseases including immune system aging.…”
Section: Mrn and Dysfunctional Telomeresmentioning
confidence: 99%
“…MRE11 inhibition in healthy T cells induced the aging phenotype, whereas MRE11 overexpression in rheumatoid arthritis T cells reverses it. The observation that the premature T cell aging is linked to MRE11 and telomere deprotection suggests MRE11 as a therapeutic target for immune aging and suppressing dysregulated inflammation (189). We expect that further knowledge of MRN biochemical mechanisms will be key to an improved understanding and intervention in multiple diseases including immune system aging.…”
Section: Mrn and Dysfunctional Telomeresmentioning
confidence: 99%
“…Early studies, utilizing measurements of telomeric length and clonal expansion of CD4 + CD28 − end-differentiated T cells, estimated that the immune aging process is accelerated by 2–3 decades in patients with RA as compared to age-matched controls (Fujii et al, 2009; Weyand et al, 2014). Molecular analysis of early CD4 + T cell responses in RA patients, modeled by activating CD4 + CD45RA + T cells and studying early effector cells, identified the nuclease MRE11A, the DNA-dependent protein kinase DNA-PKcs, and the cell cycle regulator ATM as molecular mediators of premature T cell aging (Li et al, 2016b; Shao et al, 2009, 2010). During adult life, MRE11A and ATM protein levels in CD4 + T cells gradually decline in healthy individuals.…”
Section: Maladaptive T Cell Aging: Promoter Of Tissue Inflammationmentioning
confidence: 99%
“…In RA CD4 + T cells, the lack of MRE11A nucleolytic activity is relevant for telomeric maintenance (Li et al, 2016b). MRE11A lo telomeres in RA T cells are coated by damage proteins and resemble uncapped, structurally abnormal telomeres.…”
Section: Maladaptive T Cell Aging: Promoter Of Tissue Inflammationmentioning
confidence: 99%
“…Recent work has clarified the molecular underpinning of the accelerated aging phenotype of RA T-cells. Both, naïve and memory CD4 T-cells from RA patients have a defect in the activity of the nuclease MRE11A [48]. With evolutionarily highly conserved nuclease motifs, MRE11A has both exonuclease and endonuclease activity.…”
Section: Ra T-cells – Energy-deprived and Prematurely Oldmentioning
confidence: 99%